Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy
- Author(s)
- Cochrane, T; Enrico, A; Gomez-Almaguer, D; Hadjiev, E; Lech-Maranda, E; Masszi, T; Nikitin, E; Robak, T; Weinkove, R; Wu, SJ; Manzoor, BS; Busman, T; Pai, M; Komlosi, V; Anderson, MA;
- Journal Title
- Leukemia & Lymphoma
- Publication Type
- epub ahead of print
- Publisher
- Taylor & Frances
- Research Division(s)
- Blood Cells And Blood Cancer
- PubMed ID
- 37626019
- Publisher's Version
- https://doi.org/10.1080/10428194.2023.2247511
- Open Access at Publisher's Site
https://doi.org/10.1080/10428194.2023.2247511- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-08-28 09:37:10
Last Modified: 2023-08-28 09:44:56